According to the U.S. Centers for Disease Control and Prevention (CDC), of the 39.5 million people affected by asthma, 10.5 million are children. Though it can be controlled by taking medicine and avoiding triggers, asthma is a long-term condition that can affect many people throughout their lifetime. Now, new research – funded by Novartis Pharmaceuticals, the United Kingdom National Institute for Health Research, and the European Union Airway Disease Predicting Outcomes through Patient Specific Computational Modelling (AirPROM) program – shows that the first new asthma pill in almost 20 years shows promise in significantly reducing the severity of asthma. The research was led by Prof. Chris Brightling, from the University of Leicester in the U.K., who says
August 18, 2016
A new asthma pill has been proven effective in reducing symptoms, according to the latest study.